Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescence

Journal of Reproductive Immunology

Volumn 81, Issue 1, 2009, Pages 25-33

  Gregorie, Christopher J ^a   Wiesen, Jennifer L ^a   Magner, William J ^a   Lin, Athena W ^b   Tomasi, Thomas B ^a,c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Touro University California   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Choriocarcinoma; Epigenetic regulation; HDACi; IFN ; MHC; ROS

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; HISTONE DEACETYLASE INHIBITOR; HLA DR ANTIGEN; HYDROGEN PEROXIDE; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CELL AGING; CELL STRESS; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON INDUCTION; NONHUMAN; ONCOGENE RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE; TROPHOBLASTIC TUMOR;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD40; CELL AGING; CHORIOCARCINOMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; FEMALE; GENE SILENCING; GENES, MHC CLASS I; GENES, MHC CLASS II; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INTERFERON-GAMMA; MAP KINASE SIGNALING SYSTEM; MICE; OXIDATIVE STRESS; PREGNANCY; TRANSCRIPTIONAL ACTIVATION; TROPHOBLASTS; TUMOR ESCAPE; UTERINE NEOPLASMS;

EID: 67649827335     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.02.009     Document Type: Article

References (36)

1. Bandyopadhyay D., Okan N.A., Bales E., Nascimento L., Cole P.A., and Medrano E.E. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res. 62 (2002) 6231-6239
2. Bartkova J., Rezaei R., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V.F., Kolettas E., Niforou k., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C.L., Dyrskjot L., Ãrntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., and Gorgoulis V.G. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637
3. Bihani T., Chicas A., Lo C.P.-K., and Lin A.W. Dissecting the senescence-like program in tumor cells activated by Ras signaling. J. Biol. Chem. 282 (2007) 2666-2675
4. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H.F.M., Schlegelberger B., Stein H., Dãrken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
5. Chen Q.M., Liu J., and Merrett J.B. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem. J. 347 (2000) 543-551
6. Choi J.C., Holtz R., Petroff M.G., Alfaidy N., and Murphy S. Dampening of IFN-γ-inducible gene expression in human choriocarcinoma cells is due to phosphatase-mediated inhibition of the JAK/STAT-1 pathway. J. Immunol. 178 (2007) 1598-1607
7. Chou S.D., Khan A.N., Magner W.J., and Tomasi T.B. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. Int. Immunol. 17 (2005) 1483-1494
8. Clayton A.L., and Mahadevan L.C. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett. 546 (2003) 51-58
9. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., BengurÃa A., Zaballos A., Flores J.M., Barbacid M., Beach D., and Serrano M. Tumour biology senescence in premalignant tumours. Nature 436 (2005) 642-1642
10. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190
11. Guleria I., and Sayegh M.H. Maternal acceptance of the fetus: true human tolerance. J. Immunol. 178 (2007) 3345-3351
12. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 19 (2005) 681-693
13. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
14. Khan A.N., Magner W.J., and Tomasi T.B. An epigenetically altered tumor cell vaccine. Cancer Immunol. Immunother. 53 (2004) 748-754
15. Khan A.N., Magner W.J., and Tomasi T.B. An epigenetic vaccine model active in the prevention and treatment of melanoma. J. Transl. Med. 5 (2007) 64
16. Khan A.N., Gregorie C.J., and Tomasi T.B. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. Cancer Immunol. Immunother. 57 (2008) 647-654
17. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.-X., Ferrans V.J., Howard B.H., and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274 (1999) 7936-7940
18. Lin A.W., Barradas M., Stone J., van Aelst L., Serrano M., and Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12 (1998) 3008-3019
19. Liu Y., Shepherd E.G., and Nelin L.D. MAPK phosphatases-regulating the immune response. Nat. Rev. Immunol. 7 (2007) 202-212
20. T method. Methods 25 (2001) 402-408
21. Magner W.J., Kazim A.L., Stewart C., Romano M.A., Catalano G., Grande C., Keiser N., Santaniello F., and Tomasi T.B. Activation of MHC class I, II and CD40 gene expression by histone deacetylase inhibitors. J. Immunol. 165 (2000) 7017-7024
22. Malumbres M., and Barbacid M. Ras oncogenes: the first 30 years. Nat. Rev. Cancer 3 (2003) 459-465
23. Mason D.X., Jackson T.Y., and Lin A.W. Molecular signature of oncogenic Ras-induced senescence. Oncogene 23 (2004) 9238-9246
24. Mayo M.W., Denlinger C.E., Broad R.M., Yeung F., Reilly E.T., Shi Y., and Jones D.R. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway. J. Biol. Chem. 278 (2003) 18980-18989
25. Moffett A., and Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6 (2006) 584-594
26. Morris A.C., Beresford G.W., Mooney M.R., and Boss J.M. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol. Cell. Biol. 22 (2002) 4781-4791
27. Munro J., Barr N.I., Ireland H., Morrison V., and Parkinson E.K. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp. Cell Res. 295 (2004) 525-538
28. Murphy S., and Tomasi T.B. The absence of MHC Class II antigen expression in trophoblast cells results from a lack of Class II transactivator (CIITA) gene expression. Mol. Reprod. Dev. 51 (1998) 1-12
29. Ogryzko V.V., Hirai T.H., Russanova V.R., Barbie D.A., and Howard B.H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16 (1996) 5210-5218
30. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., and Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2 (1995) 533-543
31. Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., Smyth M.J., and Johnstone R.W. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10833-10838
32. Sadek M., Hynecek R.L., Goldenberg S., Kent K.C., Marin M.L., and Faries P.L. Gene expression analysis of a porcine native abdominal aortic aneurysm model. Surgery 144 (2008) 252-258
33. Shao F., Gao Z., Marks P.A., and Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 18030-18035
34. Shay J.W., and Roninson I.B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23 (2004) 2919-2933
35. Tomasi T.B., Khan A.N.H., and Magner W.J. Epigenetic regulation of immune escape genes in cancer. Cancer Immunol. Immunother. 55 (2006) 1159-1184
36. Trowsdale J., and Betz A.G. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat. Immunol. 7 (2006) 241-246